Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Bowenoid Surprises
Description
In this talk, the speaker discusses two intriguing cases of squamous cell carcinoma in situ (SCCIS), often referred to as Bowen disease, emphasizing the complexities and controversies surrounding its classification and diagnosis. The speaker has transitioned away from using the term "Bowen's disease" due to varying interpretations among clinicians regarding its implications. The discussion highlights the speaker's preference for using traditional H&E stains over immunostains, contrasting their practice with a high-volume lab that utilizes extensive immunostaining, leading to substantial pathology bills. The cases presented illustrate challenging diagnoses characterized by pagetoid features, which can mimic Paget's disease, and involve immunostains that complicate histopathological interpretation. One case, diagnosed as squamous cell carcinoma in situ, demonstrates questionable invasive characteristics, while the second case hints at a neuroendocrine component. Ultimately, the speaker posits that many of the peculiar staining results, while interesting, may not significantly affect patient outcomes, reinforcing the perspective that excessive reliance on immunostains could obfuscate rather than clarify diagnoses. The overarching message is that despite these diagnostic challenges, these squamous cell carcinomas live within identifiable parameters, and understanding their essence does not necessitate immunostain usage.
View moreConclusions
- Bowenoid lesions may sometimes resemble other conditions such as Paget's disease or Merkel cell carcinoma.
- The distinction between Bowen's disease and other carcinomas is not always clear without the use of immunostains.
- Bowen's disease, or carcinoma in situ, is often obvious and does not necessarily require special stains for diagnosis.
- Immunostains can complicate or confuse the diagnosis instead of clarifying it in certain cases.
- Over-reliance on immunostains can lead to unnecessary complications in the evaluation of skin lesions.
- Staining patterns should not overshadow the clinical diagnosis, particularly in well-established conditions like Bowen's disease.
- There may be cases where Bowen's disease coexists with other conditions like extramammary Paget's disease, suggesting a shared cell of origin.
- Ultimately, many cases identified through immunostaining do not change the management or outcome for the patient.
- Matsumoto et al, 2007 https://doi.org/10.1111/j.1600-0560.2007.00732.x
- Tammie Ferringer, Hudson C. Rogers, John S. Metcalf First published: 15 December 2004 https://doi.org/10.1111/j.0303-6987.2005.00270.x
- Belinda H. Tan, Klaus J. Busam, Melissa P. Pulitzer First published: 24 April 2012